Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Treg Cell in the Treatment of GVHD After Allogeneic Hematopoietic Stem Cell Transplantation

NCT06411184 is registered in ClinicalTrials.gov with Xuzhou Medical University as lead sponsor.

NCT NCT06411184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06411184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Treg Cell in the Treatment of GVHD After Allogeneic Hematopoietic Stem Cell Transplantation
Lead sponsor
Xuzhou Medical University
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
June 1, 2024
Completion date
May 31, 2027
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gvhd